A study based on a mix of probiotics selected according to 5 criteria
A study is currently ongoing in Italy. Enrolling 100 autistic patients aged 18 to 72 months, it aims to measure the effectiveness of a 6 month supplementation of the multi-strain high concentration probiotic blend Vivomixx. The evaluation criteria for this study focus on the severity of autistic behaviors, gastrointestinal symptoms and the encephalogram of patients.
The implementation of this new study is based on criteria of efficacy and safety of use of this mix of bateria that have demonstrated in previous clinical studies and give hope for improvement in this complex disorder.
1. Selection of strains by objective criteria
- selection of 8 probiotic strains with specific and defined functional and metabolic properties, measurable by objective criteria.
- controlled manufacturing process
- evaluation carried out on the final mix and not on the separated strains (synergistic action of the mix demonstrated)
Reference *Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters
Details of this ongoing study available in English on Clinical Trials.gov (USA)